NCT03434730 2025-04-22Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood TransplantationMemorial Sloan Kettering Cancer CenterPhase 2 Completed46 enrolled
NCT02906371 2021-07-02Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release SyndromeUniversity of PennsylvaniaPhase 1 Completed80 enrolled